补体成分C5和C9的血浆水平与凝血酶生成相关
在770例静脉血栓患者(MARTHA研究)中,用多组学方法检测377种抗体与凝血酶生成试验(TGA)参数的关联,筛选出与至少3个TGA参数相关的蛋白,并在536名健康人(EFS-AM)中验证。补体C5和C9在两组中关联最强;体外补充纯化C9对TGA参数有显著剂量依赖效应,C5无效应。结论认为C5和C9是凝血酶生成的潜在决定因素,需进一步研究确定因果关系和机制。
要点
- 在MARTHA研究的770例静脉血栓患者中,18种蛋白与至少3个TGA参数相关(P < 1.33 × 10⁻⁴),其中13种在EFS-AM的536名健康人中呈相似关联模式。
- 补体C5和C9在两组中关联最强;体外向乏血小板血浆补充纯化C9对TGA参数有显著剂量依赖效应,补充纯化C5未观察到效应。
- C5错义变异rs17611与C5水平降低、内源性凝血酶潜能和峰值降低相关(MARTHA),但该变异与TGA参数在EFS-AM中无关联。
核心结论
- 本研究识别出补体蛋白C5和C9是凝血酶生成的潜在决定因素。
- 需进一步研究以确定因果关系并阐明潜在机制。
研究设计与样本
- 研究采用多组学方法,在770例来自MARTHA研究的静脉血栓患者中,用多元线性回归分析检测TGA参数与377种靶向236种心血管风险候选蛋白的抗体的关联。
- 与至少3个TGA参数相关的蛋白在536名健康人(EFS-AM)中验证;两组中关联最强的蛋白进一步进行遗传分析和体外实验。
主要发现
- 在MARTHA中,18种蛋白与至少3个TGA参数相关(P < 1.33 × 10⁻⁴),其中13种在EFS-AM中呈现相似的关联模式。
- 补体C5和C9在两组中关联最强。
- 体外向乏血小板血浆补充纯化C9蛋白对TGA参数有显著剂量依赖效应;补充纯化C5未观察到效应。
- 鉴定出多个与C5和C9血浆水平相关的单核苷酸多态性,其中最强关联为C5错义变异rs17611,在MARTHA中与C5水平、内源性凝血酶潜能和峰值降低相关。
- 该变异与TGA参数在EFS-AM中无关联。
关键数值与推荐
- 蛋白与TGA参数的关联在MARTHA中的显著性阈值为P < 1.33 × 10⁻⁴。
- 筛选标准为与至少3个TGA参数相关的蛋白进入验证。
- C5错义变异rs17611在MARTHA中与C5水平、内源性凝血酶潜能和峰值降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究以确定因果关系并阐明潜在机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The thrombin generation assay (TGA) evaluates the potential of plasma to generate thrombin over time, providing a global picture of an individual's hemostatic balance. OBJECTIVES: This study aimed to identify novel biological determinants of thrombin generation using a multiomics approach. METHODS: Associations between TGA parameters and plasma levels of 377 antibodies targeting 236 candidate proteins for cardiovascular risk were tested using multiple linear regression analysis in 770 individuals with venous thrombosis from the Marseille Thrombosis Association (MARTHA) study. Proteins associated with at least 3 TGA parameters were selected for validation in an independent population of 536 healthy individuals (Etablissement Français du Sang Alpes-Méditerranée [EFS-AM]). Proteins with strongest associations in both groups underwent additional genetic analyses and in vitro experiments. RESULTS: Eighteen proteins were associated (P < 1.33 × 10⁻4) with at least 3 TGA parameters in MARTHA, among which 13 demonstrated a similar pattern of associations in EFS-AM. Complement proteins C5 and C9 had the strongest associations in both groups. Ex vivo supplementation of platelet-poor plasma with purified C9 protein had a significant dose-dependent effect on TGA parameters. No effect was observed with purified C5. Several single nucleotide polymorphisms associated with C5 and C9 plasma levels were identified, with the strongest association for the C5 missense variant rs17611, which was associated with a decrease in C5 levels, endogenous thrombin potential, and peak in MARTHA. No association of this variant with TGA parameters was observed in EFS-AM. CONCLUSION: This study identified complement proteins C5 and C9 as potential determinants of thrombin generation. Further studies are warranted to establish causality and elucidate the underlying mechanisms.
引用
- Vacik Díaz R, Munsch G, Iglesias MJ, et al. Plasma levels of complement components C5 and C9 are associated with thrombin generation. J Thromb Haemost. 2024. PMID: 38838952. doi:10.1016/j.jtha.2024.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。